Biosketch / Results /
Bernard A. Feigenbaum, M.D.Clinical Assistant Professor;
Departments of Medicine (GIM Div Dir) and Otolaryngology (Otolaryngology)
Clinical Addresses14 PENN PLAZA, 225 WEST 34TH STREET
NEW YORK, NY 10122
Handicap Access: yes
Medical SpecialtiesPediatric Allergy & Immunology, Allergy & Immunology
Medical ExpertiseChronic Cough, Drug Allergy, Food Allergy, Eosinophilic Esophagitis, Asthma, Eczema/Atopic Dermatitis, Allergic Rhinitis (Hayfever), Allergy And Immunology, Sinusitis
Clinical Responsibilities**New phone due to storm (646) 664-1099** Bernard A. Feigenbaum, MD, FACP, FAAAAI is Director of the NYU Adverse Drug Reaction and Desensitization Program, and Clinical Assistant Professor of Medicine and Otolaryngology. He has over fifteen years of clinical and teaching experience and is Board-Certified in Allergy & Immunology.
Dr. Feigenbaum serves as a Medical Expert Consultant for an office of the NY State Board for Professional Medical Conduct, and has served as an expert witness and/or consultant in federal or state actions in five states.
Dr. Feigenbaum is passionate about improving medical care, and is known for his friendly, caring manner and for his teaching skills. He has given presentations about Professionalism in Medicine for the American Board of Internal Medicine, and recently lectured at Memorial Sloan-Kettering, Hospital for Special Surgery, Hospital for Joint Diseases, NYU Langone Medical Center, and the NYC Department of Health.
Dr. Feigenbaum is a Principal Investigator at NYULMC, and his recent translational study of mycotoxins in chronic rhinosinusitis will be published in Otolaryngology-Head and Neck Surgery. Research interests include asthma; sinus disease; drug allergy; and dermatologic allergy. He has had 15 articles, abstracts and/or letters accepted for publication and is a peer reviewer for Annals of Internal Medicine and Journal of Allergy & Clinical Immunology. National committee assignments include Vice Chair of the Asthma & Respiratory Disease Committee (American College of Allergy, Asthma & Immunology); and Asthma Diagnosis Committee; Rhinosinusitis Committee; and (Drug) Desensitization Task Force (American Academy of Allergy, Asthma & Immunology).
Dr. Feigenbaum has been featured on the air on Good Morning America, Sirius Radio, CBS News Radio, and the Rachael Ray Show, and has been quoted by NY Daily News and Los Angeles Times.
Dr. Feigenbaum is one of the few allergists in NYC to routinely perform aspirin desensitization, antibiotic desensitization, chemotherapy desensitization, and monoclonal desensitization.
Conditions treated in the office include allergic rhinitis and asthma; eczema/dermatitis; chronic cough; acute and chronic sinusitis; food allergy and eosinophilic esophagitis; aspirin exacerbated respiratory disease (AERD) and other allergic diseases. Office testing and procedures include skin testing for food and airborne allergies; patch testing for contact dermatitis; drug desensitization; and pulmonary function testing.
InsuranceAETNA HMO, AETNA INDEMNITY, AETNA MEDICARE, AETNA POS, AETNA PPO, Beech Street, Cigna HMO, Cigna POS, Cigna PPO, Empire BCBS EPO, Empire BCBS HMO, Empire BCBS Indemnity, Empire BCBS MediBlue (Medicare), Empire BCBS POS, Empire BCBS PPO, Great West Insurance, HEALTHNET HMO, HEALTHNET PPO, HIP ACCESS I, HIP ACCESS II, HIP Child Health Plus, HIP EPO, HIP Family Health Plus, HIP HMO, HIP MEDICARE, HIP PPO, HealthFirst (Medicaid), Multiplan, NYS EMPIRE PLAN, Oxford Freedom Plan, Oxford Medicare, Private Healthcare Systems (PHCS), UHC EPO, UHC HMO, UHC POS, UHC PPO, UHC TOP TIER, UPN Elite (Island Group/Humana/etc)
Insurance Disclaimer: Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have changed.
Board Certification2003 — Ab Allergy & Immunology (Clinical & Laboratory Immunology)
Education1989 — Boston University Medical Center, Medical Education
1989-1990 — Mercy Hospital and Medical Center (Internal Medicine), Internship
1990-1992 — Mercy Hospital and Medical Center (Internal Medicine), Residency Training
1993-1995 — Mercy Hospital and Medical Center (Immunology & Allergy), Residency Training
1993-1995 — Scripps Memorial Hospital-La Jolla (Allergy), Clinical Fellowships
Research InterestsDr. Feigenbaum is a Principal Investigator at NYU Langone, in a translational study relating to the etiology of chronic sinusitis; and in a study of knowledge of pulmonary function, anaphylaxis and radiocontrast media (RCM) allergy. He has a research interest in asthma, sinus disease and drug allergy and is a peer reviewer for the Annals of Internal Medicine and the Journal of Allergy & Clinical Immunology. He has published articles, abstracts or letters on: aspirin-sensitive asthma; reflux in asthma; bee sting allergy; vocal cord dysfunction; and nitric oxide in asthma.
Research KeywordsAsthma; "Food Allergy"; Hives; Allergy
All data from NYU Health Sciences Library Faculty Bibliography — -
Measurement of mycotoxins in patients with chronic rhinosinusitis
Lieberman S.M.; Jacobs J.B.; Lebowitz R.A.; Feigenbaum B.A.
2011 ;127(2 SUPPL 1):AB123-AB123, Journal of allergy & clinical immunology
— id: 127252, year: 2011, vol: 127, page: AB123, stat: Journal Article,
Measurement of Mycotoxins in Patients with Chronic Rhinosinusitis
Lieberman SM; Jacobs JB; Lebowitz RA; Fitzgerald MB; Crawford J; Feigenbaum BA
2011 Aug;145(2):327-329, Otolaryngology, head & neck surgery
— id: 137919, year: 2011, vol: 145, page: 327, stat: Journal Article,
Rapid desensitization did not prevent febrile idiosyncratic reactions to oxaliplatin
Mathew A.; Ballas M.S.; Gorsky M.; Feigenbaum B.A.
2011 ;127(2 SUPPL 1):AB195-AB195, Journal of allergy & clinical immunology
— id: 127253, year: 2011, vol: 127, page: AB195, stat: Journal Article,
Immediate hypersensitivity reaction and successful rapid desensitization to rituximab followed by serum sickness in a 4 year old
Romanos-Sirakis E.; Feigenbaum B.A.
2011 ;127(2 SUPPL 1):AB198-AB198, Journal of allergy & clinical immunology
— id: 127255, year: 2011, vol: 127, page: AB198, stat: Journal Article,
Special considerations for rapid drug desensitization with natalizumab
Sutaria M.; Miro K.; Mathew A.; Kister I.; Feigenbaum B.A.
2011 ;127(2 SUPPL 1):AB196-AB196, Journal of allergy & clinical immunology
— id: 127254, year: 2011, vol: 127, page: AB196, stat: Journal Article,
Iatrogenic Hypogammaglobulinemia Resembling Common Variable Immunodeficiency
Mathew A; Feigenbaum BA; Miro K; Weinfeld JN
2010 ;105:A101-A101, Annals of allergy, asthma & immunology
— id: 134324, year: 2010, vol: 105, page: A101, stat: Journal Article,
Successful Oxaliplatin Desensitization After Unsuccessful Infusion Using A Hypersensitivity Protocol
Miro K; Feigenbaum BA; Mathew A; Weinfeld JN
2010 ;105:A27-A27, Annals of allergy, asthma & immunology
— id: 134323, year: 2010, vol: 105, page: A27, stat: Journal Article,
Fractional exhaled nitric oxide in patients with atopic asthma: correct definitions of the terms atopy and asthma
Feigenbaum, Bernard A
2008 Jul;101(1):110-110, Annals of allergy, asthma & immunology
— id: 80334, year: 2008, vol: 101, page: 110, stat: Journal Article,
Self-reported, doctor-diagnosed "asthma" is not necessarily asthma: 78.9% of these "asthma" cases were atopic
Feigenbaum, Bernard A
2008 May;121(5):1291; author reply 1291-1291; author reply 1292, Journal of allergy & clinical immunology
— id: 80335, year: 2008, vol: 121, page: 1291; author reply 1291, stat: Journal Article,
Insect-sting challenges--all risk and no benefit?
1995 Nov;96(5 Pt 1):704-705, Journal of allergy & clinical immunology
— id: 64106, year: 1995, vol: 96, page: 704, stat: Journal Article,
A case of vocal cord dysfunction mimicking asthma
Feigenbaum BA; Simon RA
1995 ;74:92-92, Annals o